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Abstract
Proteinases play a pivotal role in wound healing by regulating cell-matrix interactions and availability of bioactive
molecules. The role of matrix metalloproteinase-13 (MMP-13) in granulation tissue growth was studied in subcutaneously
implanted viscose cellulose sponge in MMP-13 knockout (Mmp13
2/2) and wild type (WT) mice. The tissue samples were
harvested at time points day 7, 14 and 21 and subjected to histological analysis and gene expression profiling. Granulation
tissue growth was significantly reduced (42%) at day 21 in Mmp13
2/2 mice. Granulation tissue in Mmp13
2/2 mice showed
delayed organization of myofibroblasts, increased microvascular density at day 14, and virtual absence of large vessels at
day 21. Gene expression profiling identified differentially expressed genes in Mmp13
2/2 mouse granulation tissue involved
in biological functions including inflammatory response, angiogenesis, cellular movement, cellular growth and proliferation
and proteolysis. Among genes linked to angiogenesis, Adamts4 and Npy were significantly upregulated in early granulation
tissue in Mmp13
2/2 mice, and a set of genes involved in leukocyte motility including Il6 were systematically downregulated
at day 14. The expression of Pdgfd was downregulated in Mmp13
2/2 granulation tissue in all time points. The expression of
matrix metalloproteinases Mmp2, Mmp3, Mmp9 was also significantly downregulated in granulation tissue of Mmp13
2/2
mice compared to WT mice. Mmp13
2/2 mouse skin fibroblasts displayed altered cell morphology and impaired ability to
contract collagen gel and decreased production of MMP-2. These results provide evidence for an important role for MMP-13
in wound healing by coordinating cellular activities important in the growth and maturation of granulation tissue, including
myofibroblast function, inflammation, angiogenesis, and proteolysis.
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Introduction
Wound repair is a fundamental process for survival of
multicellular organisms. Mammalian wound healing consists of
functionally distinct and temporally overlapping processes, i.e.
hemostasis and inflammation, re-epithelialization and granulation
tissue formation, and tissue remodeling [1]. These processes
involve functions of multiple cell types in distinct tissue compart-
ments, and they are strictly orchestrated by various growth factors,
cytokines and extracellular matrix (ECM) components [1,2].
Proteolytic activity plays a pivotal role in cutaneous wound
repair [3,4]. The main classes of proteinases in wound are serine
proteinases of plasminogen activator-plasmin system and matrix
metalloproteinases (MMPs). MMPs are a family of Zn-dependent
endopeptidases, which as a group can cleave a multitude of ECM
proteins and non-matrix proteins, including other proteinases,
proteinase inhibitors, growth factors, cytokines, and cell surface
receptors [3,4]. In addition, members of ADAM (a disintegrin and
metalloproteinase domain) and ADAMTS (a disintegrin and
metalloproteinase domain with thrombospondin motifs) families,
including ADAM-9 and ADAMTS-1, have been implicated in
wound healing [5,6].
The expression of MMPs in intact skin is low, but cellular
stimuli generated by cutaneous injury result in induction of the
expression of several MMPs, and MMP activity in general is
essential for normal wound healing [3,4,7,8]. Initially, certain
MMPs (MMP-1, MMP-2) are released to injured tissue by
aggregating platelets [3,4]. MMPs expressed by cells in human
acute cutaneous wounds include collagenase-1 (MMP-1), collage-
nase-2 (MMP-8) [9,10], gelatinase-A (MMP-2), gelatinase-B
PLoS ONE | www.plosone.org 1 August 2012 | Volume 7 | Issue 8 | e42596(MMP-9) [11], stromelysin-1 (MMP-3), stromelysin-2 (MMP-10)
[12], MT1-MMP [11], MMP-19 [13], MMP-26 [14], and MMP-
28 [15]. In adult human skin wounds, MMP-1 is expressed by
keratinocytes at the epithelial tip and by fibroblasts in the
granulation tissue [9]. MMP-1 is required for keratinocyte
migration on collagen, which is an important feature in the
initiation of re-epithelialization [16]. In addition, MMP-1 has been
suggested to mediate collagen remodeling during wound healing
and wound bed maturation [12,17]. In murine skin, MMP-1 is
substituted by mouse interstitial collagenase MMP-13, a close
structural homologue of human MMP-13 (collagenase-3) [18].
The tissue specific expression pattern of mouse MMP-13 indicates
functional homology between mouse MMP-13 and both human
MMP-1 and MMP-13 [9,19–22].
The expression of MMP-13 is not detected in normally healing
human adult skin wounds, but abundant expression of MMP-13
by fibroblasts in chronic cutaneous ulcers has been documented
[23]. In contrast, the expression of human MMP-13 by fibroblasts
has been noted in normal human gingival and fetal skin wounds
characterized by scarless wound healing [24,25]. MMP-13 has
been shown to enhance the remodeling of 3-dimensional (3D)
collagen matrix, cell morphology and cell viability of dermal
fibroblasts in vitro [26]. However, the mechanistic role of MMP-13
in wound granulation tissue growth and remodeling in vivo is not
clear [27,28].
In this study, we have investigated the role of MMP-13
specifically in the formation of wound granulation tissue. We have
utilized a well defined model of experimental granulation tissue
induced by viscose cellulose sponge (VCS) in MMP-13 knockout
(Mmp13
2/2) mice [29]. The results showed a marked delay in
granulation tissue growth in Mmp13
2/2 mice accompanied with a
delay in organization of myofibroblasts and formation of large
blood vessels. Using global gene expression profiling we identified
sets of differentially expressed genes in Mmp13
2/2 and wild type
(WT) mouse granulation tissue involved in cellular processes such
as cellular movement, inflammatory response, cellular growth and proliferation,
as well as cell death and proteolysis. Among genes involved in
angiogenesis, Adamts4 and Npy were specifically upregulated in
early granulation tissue of Mmp13
2/2 mouse characterized by
increased microvessel density, and Pdgfd was generally downreg-
ulated. Also inflammatory cytokine gene Il6 was downregulated in
early Mmp13
2/2 granulation tissue. These results provide
evidence for a pivotal role for MMP-13 in regulating cellular
functions important in the growth of granulation tissue, including
myofibroblast function, angiogenesis, inflammation, and proteol-
ysis.
Materials and Methods
Ethics statement
All mouse experiments were performed according to institu-
tional guidelines of the University of Turku and with the
permission of the animal test review board of the Regional
Government of Southern Finland.
Experimental mouse granulation tissue model
The establishment of experimental granulation tissue was
performed as previously described [30,31]. Wild type (WT) and
MMP-13 knockout (Mmp13
2/2) mice (males, age 5.5–8 wk) [29],
were anesthetized with Hypnorm-Dormicum solution. A single
vertical incision was made to dorsal skin under aseptic conditions,
a sterile rectangular viscose cellulose sponge (VCS; Cellomeda Oy,
Turku, Finland) of size 565610 mm
3 was implanted horizontally
under the skin at cranial location, and the wound was closed with
continuous monofilament 4-0 suture (Prolene; Ethicon, Norder-
stedt, Germany). Both Mmp13
2/2 and WT mice recovered well
from surgical VCS implantation and during the experiment, no
wound infections or other complications were observed. The mice
(n=5–6/group) were sacrificed 7, 14, and 21 days after
implantation, the sponges were removed and cut into four pieces.
Two inner parts of VCS were either frozen with Tissue-Tek
O.C.T. Compound (Sakura, Finetek) in liquid nitrogen or fixed in
10% neutral buffered formalin for 24 h and embedded in paraffin
for histological assessment. The remaining parts of the rectangular
VCS were frozen in liquid nitrogen for RNA extraction (Qiagen
RNeasy kit, Qiagen GmbH, Hilden, Germany).
Histological and morphometrical analysis of mouse
granulation tissue
Formalin-fixed, paraffin-embedded tissue sections were pro-
cessed for hematoxylin and eosin (HE) staining and subjected for
microscopic evaluation. The mosaic images of representative
samples were obtained using Zeiss Axiovert 200 M microscope
with 106 objective and Axiovision 4.3 software (Carl Zeiss
MicroImaging GmbH, Germany). To quantify the tissue growth
inside VCS HE-stained tissue sections of all samples were scanned.
The portion of cellular area of the total implant area was
determined utilizing image analysis with cell
D 2.6 software
(Olympus Soft Imaging Solutions GmbH) and performed as blind
analysis. The capsule composed of loose connective tissue present
occasionally around the implant was not included in the measured
area. To assess deposition of collagen and other fibrous ECM by
granulation tissue cells, tissue sections were stained with van
Gieson and Gomori’s staining methods. The statistical analyses
were performed using Independent samples T-test with SPSS 16.0
software.
Immunohistochemistry
Formalin-fixed paraffin-embedded sections were rehydrated
and processed for immunohistochemical (IHC) staining with
biotin-streptavidin-peroxidase complex (ABC) –based visualization
system (Vectastain ABC Kit; Vector Laboratories, Inc. Burlin-
game, CA, USA) and using diaminobenzidine (DAB) as substrate,
as previously described [32]. The primary antibodies against
mouse CD34 (0.4 mg/ml; MEC 14.7, Santa Cruz) and a-smooth
muscle actin (a-SMA) (1:2000; 1A4, A2547, Sigma) were used. For
negative control staining, the primary antibodies were omitted and
replaced by blocking reagent.
The orientation of a-SMA-positive myofibroblasts was assessed
by scoring as follows: weak (+), moderate (++) and strong (+++)
(Table 1). Statistical significance was determined using Pearson’s
x
2-test. Blood vessel formation was assessed by determining the
density of CD34 positive vessel structures in a defined area of each
sample. The diameter of vessels was morphometrically analyzed
with image analysis using cell
D 2.6 software, and the vessels were
divided into subgroups based on their diameter. Statistical
significance was determined using Mann-Whitney U test.
Gene expression profiling of mouse granulation tissue
Genome wide gene expression profiling in mouse experimental
granulation tissue (day 7, n=3; day 14, n=4; day 21, n=4 for
both genotypes) with Affymetrix GeneChipH 39 IVT Expression
Analysis was performed at The Finnish DNA Microarray and
Sequencing Centre, Turku, Finland. Aliquots of total RNA were
processed according to Affymetrix’s instructions and hybridized to
Mouse Genome 430 2.0 oligonucleotide array (Affymetrix, Santa
Clara, CA). The data quality was checked with AGCC and
MMP-13 in Wound Granulation Tissue
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TM 1.1. The data were normalized between
the chips using rma and subjected for statistical testing with
Chipster v1.4.7 software (CSC - IT Center for Science Ltd.,
Espoo, Finland). Statistical significances for differentially expressed
genes were determined using linear modeling. The gene expres-
sion pattern was evaluated as comparison of the genotypes in a
given time point. Moreover, differentially expressed genes were
determined between two consecutive time points in WT samples.
The fold change (FC) value for differentially expressed genes is
essentially the log2 of the ratio between the mean expression
values of the two sample groups. Further data mining was
performed using Ingenuity Pathway Analysis (IPAH) software
(http://www.ingenuity.com/). The data sets from genotype
comparisons in each time point were analyzed using threshold
P,0.05 and FC.0.5, which was chosen based on volcano plot
data visualization. Illustration of the data was performed with
IPAH and RGui v2.11.1 software. All microarray data are
MIAME compliant and have been deposited in the public
database GEO (Gene Expression Omnibus, NCBI; accession
number GSE38822).
Real-time quantitative RT-PCR
For quantitative analysis of the selected mRNAs aliquots of total
RNA were DNase-treated, reverse-transcribed to cDNA and
analyzed using real-time quantitative RT-PCR (qRT-PCR) with
TaqManH technology and Applied Biosystem’s 7900HT equip-
ment [33]. For mouse neuropeptide Y (Npy) mRNA, pre-designed
TaqManH Gene Expression assay was used (ID
Mm03048253_m1, Applied Biosystems). For other transcripts,
oligonucleotide primers and dual-labeled probes were designed
using RealTimeDesign
TM software (Biosearch Technologies, Inc)
(Table S1). The levels of b-actin mRNA were used to normalize
the results between the samples. The samples were analyzed in
three technical replicates. To determine statistical significance of
the results, the data were analyzed with independent samples T-
test.
Culture of mouse skin fibroblasts
WT and Mmp13
2/2 mouse [29] skin fibroblasts (MSF) from
three individual mice for each genotype were established by
explantation from the skin of 3 weeks old male and female mice.
Dorsal skin pieces (161 mm) were allowed to attach on cell culture
dish for 10 min and covered with DMEM containing heat-
inactivated fetal calf serum (FCS, 20%), L-glutamine (2 mM),
penicillin G (150 IU/ml), streptomycin (150 mg/ml) and Ampho-
tericin B (1 mg/ml). After 10 days of cultivation, the skin pieces
were removed and the fibroblasts cultured until subconfluency.
WT and Mmp13
2/2 fibroblasts were seeded and cultured in 3D
collagen gel, as previously described [26]. The cells were
suspended in bovine collagen suspension consisting of 7/10
PureColH (97% type I atelocollagen, 3 mg/ml, Advanced BioMa-
trix), 1/10 NaOH in 0.2 M Hepes buffer pH 8 and 1/5
56DMEM in density 5610
5 cells/ml for contraction assay and
2610
5 cells/ml for visualizing cell morphology, and 300 ml
aliquots were applied into wells of 24-well plate. After solidification
(1–2 h, 37uC), the gels were detached from the well edges and
DMEM containing 0.5% or 10% FCS was added. In certain
cultures, medium was supplemented with transforming growth
factor-b (TGF-b) (5 ng/ml). Collagen gel contraction was assessed
after 24 h and 48 h by quantifying the gel areas using cell
D 2.6
image analysis software. Alternatively, the gel was left attached in
the well, released after 72 h, and the contraction was assessed 24 h
later. To visualize cell morphology, the gels were fixed with 4%
paraformaldehyde (37uC) after 24 h cultivation, stained with
fluorescently labeled phalloidin and Hoechst 33342, and examined
in a microscope.
Gelatinase zymography
Aliquots of unheated conditioned media were fractionated in
10% SDS-PAGE containing 1 mg/ml gelatin (G-6269, Sigma)
which was fluorescently labeled with MDPF (645989, Fluka). The
gels were washed and subsequently incubated for 48 h in a
gelatinase activating buffer as described in [34], and photographed
under UV-light.
Results
Delayed granulation tissue growth in Mmp13
2/2 mice
To elucidate the role of MMP-13 specifically in the formation of
wound granulation tissue involved in the wound healing process,
subcutaneously implanted viscose cellulose sponge (VCS) was used
to induce granulation tissue growth. This model has been well
characterized and shown to be comparable to the formation of
granulation tissue during cutaneous wound healing [30,31].
Histological analysis revealed similar initial growth of granulation
tissue into VCS at 7 d and 14 d in WT and Mmp13
2/2 mice,
characterized by influx of inflammatory cells and fibroblast-like
cells, and ingrowth of vessel structures (Figure 1A and C). Van
Gieson staining for ECM fibers indicated similar ECM deposition
in Mmp13
2/2 and WT mice adjacent to the implant surface (data
not shown). However, at 21 d, the Mmp13
2/2 granulation tissue
was clearly different from WT tissue as demonstrated by a
significant reduction (42%, P,0.05) in the growth of granulation
tissue in Mmp13
2/2 mice compared to WT mice at 21 d
(Figure 1A and B). The result suggests an important role for
MMP-13 in regulating the cellular events related to granulation
tissue formation, especially in the later phase characterized by
deeper tissue growth.
Delayed maturation of myofibroblasts in Mmp13
2/2
mouse granulation tissue
The appearance of myofibroblasts in wound granulation tissue
is important for wound contraction during epithelial repair [35].
To assess the presence of myofibroblasts in mouse experimental
granulation tissue, sections harvested at 7, 14 and 21 d, were
Table 1. Evaluation of myofibroblast orientation in WT and
Mmp13
2/2 mouse granulation tissue.
Time point Genotype + ++ +++ p-value
7d WT 0 2 3 ,0.05
Mmp13
2/2 33 0
14 d WT 0 2 4 n.s.
Mmp13
2/2 02 3
21 d WT 3 2 0 ,0.05
Mmp13
2/2 02 3
Sections of experimental granulation tissue of wild-type (WT) and MMP-13
knockout (Mmp13
2/2) mice were stained for myofibroblasts with a-SMA
antibody and analyzed for myofibroblast orientation. Scoring: +, weak; ++,
moderate; +++, strong. Scoring is based on the parallel orientation of
myofibroblasts to the implant surface where weak implies negligible
orientation, moderate implies lining of occasional myofibroblasts in certain
areas, and strong indicates intensive parallel lining of myofibroblast masses.
Statistical significance (p) was determined by Pearson’s x
2-test. n.s., not
significant.
doi:10.1371/journal.pone.0042596.t001
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detected in the areas adjacent to implant surface in WT mouse
tissue and the staining pattern was typically dense and oriented
parallel to the surface in accordance with the contractile function
of myofibroblasts. In Mmp13
2/2 mice the orientation of a-SMA-
positive myofibroblasts was more random than in WT mice and
did not display unified assembly of myofibroblast masses at 7 d. A
semi-quantitative evaluation of the staining revealed a significant
difference in the collective parallel orientation at 7 d, suggesting
altered function and delayed maturation of myofibroblasts
(Figure 2A and Table 1). Analysis of the granulation tissue
harvested at 14 d showed prominent staining pattern of a-SMA
positive cells extending throughout the cellular area and showing
strong parallel orientation of myofibroblasts especially in the areas
close to VCS surface (Figure 2B). No obvious difference was noted
between Mmp13
2/2 and WT tissues, suggesting that although lack
of MMP-13 results in delayed maturation of myofibroblasts in the
granulation tissue, this effect is subsequently compensated by other
factors. Interestingly, at 21 d the a-SMA staining pattern was
characterized by markedly diminished number of a-SMA-positive
cells in the areas close to VCS surface apparently representing the
most mature granulation tissue, and the a-SMA staining was more
emphasized in the inner parts of the implant. The shift in the
expression pattern of a-SMA was clearly more evident in WT than
in Mmp13
2/2 tissue and appeared to be in accordance with the
intensive tissue ingrowth (Figure 2B).
Altered vascularization in the granulation tissue of
Mmp13
2/2 mice
To examine the role of MMP-13 in vascularization of the
experimental granulation tissue, the tissue sections were stained for
CD34 by IHC. The CD34-positive vessels were morphometrically
analyzed and subdivided into three groups based on the diameter.
The vessel structures with the diameter less than 10 mm were
considered as microvessels, the vessels with the diameter 10–
40 mm as medium sized blood vessels, and the vessels over 40 mm
in diameter as large vessels. In general, CD34 positive blood
vessels were abundantly present in WT and Mmp13
2/2 mouse
granulation tissue already at 7 d time point in the areas with
prominent tissue growth (Figure 3A). In both groups, the vessel
density decreased during the second week of granulation tissue
growth and increased again during the third week. CD34 positive
microvessels (,10 mm) were abundantly present in both WT and
Figure 1. Delayed growth of experimental granulation tissue in Mmp13
2/2 mice. Subcutaneous viscose cellulose sponges (VCS) implanted
in wild type (WT) and MMP-13 knockout (Mmp13
2/2) mice were harvested at different time points, as indicated. (A) Hematoxylin-eosin staining of
representative sections demonstrating reduced growth of granulation tissue in Mmp13
2/2 mice at 21 d. The border of cellular granulation tissue is
marked with dashed line. The area enclosed by a square is shown in (C) with higher magnification. (Scale bar=1 mm). (B) The growth of granulation
tissue inside VCS was quantified blinded by determining the portion of cellular tissue relative to the implant area in a tissue section. The border of
granulation tissue was determined as exemplified with dashed lines in (A). (*P,0.05, Independent samples T-test, n=5–6). (C) Higher resolution
images from the tissue sections presented in (A) showing the border region at the endpoint of the granulation tissue (the area enclosed by a square
in A). (s, implant surface; scale bar=200 mm).
doi:10.1371/journal.pone.0042596.g001
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2/2 mouse granulation tissue in all time points examined
(Figure 3B). Interestingly, microvessel density was higher in
Mmp13
2/2 mouse granulation tissue at 14 d (P,0.05), reflecting
enhanced neovascularization or reduced resolution. The density of
the medium sized vessels (10–40 mm) was similar in WT and
Mmp13
2/2 tissue in all time points examined (Figure 3A and B). A
striking difference in vascular pattern was also noted at 21 d, when
the Mmp13
2/2 granulation tissue was characterized by almost
total absence of large vessels (.40 mm), likely to represent venules
or arterioles, which in contrast, were commonly present in WT
mouse granulation tissue (Figure 3A and B) (P,0.05). Determi-
nation of the total number of large vessels at 21 d time point
revealed that a section of every granulation tissue sample
contained in average 14 (range 5–24) and 2 (range 0–4) large
vessels in WT and Mmp13
2/2 mouse granulation tissue, respec-
tively.
Comparison of gene expression profiles between
Mmp13
2/2 and WT mouse granulation tissue
To gain insight into the molecular mechanisms of MMP-13 -
elicited regulation of granulation tissue growth and vasculariza-
tion, RNAs from WT and Mmp13
2/2 mouse granulation tissue
samples were subjected to oligonucleotide microarray (Affymetrix)
based global gene expression profiling. The data were analyzed by
comparison of the gene expression profiles of Mmp13
2/2 and WT
tissue in all time points. Here, 1303, 3560 and 1984 significantly
differentially expressed genes (P,0.05) were identified at 7 d, 14 d
and 21 d, respectively. Of these 87, 96 and 95 genes, respectively,
displayed FC.0.75 and are listed in heatmap in Figure 4A.
Classification of differentially expressed genes between the
genotypes at specific time points based on the molecular function
revealed the peptidases and other enzymes and the group of
unclassified genes (‘‘other’’) as the largest groups at 7 d (Figure 4B).
The majority of the differentially expressed transcripts at 7 d were
upregulated in Mmp13
2/2 mouse granulation tissue, including
remarkable upregulation of interferon activated gene 202B
(Ifi202b, p202;F C ,8) and cell adhesion molecule 1 (Cadm1;
FC,2.5), which both are associated with negative regulation of
cell growth [37,38]. Interestingly, the expression of minor
histocompatibility antigen 60a (H60a) was markedly upregulated
in Mmp13
2/2 tissue at 7 d and 14 d (FC,4 and FC,3,
respectively). In addition to upregulation of Adamts4 and down-
regulation of serine/cysteine peptidase inhibitors Serpina1b and
Serpina3n in Mmp13
2/2 mice, no other signs of positive regulation
of endopeptidase activity, which could potentially compensate
MMP-13 deficiency, was recognized. It is of note that Il6 which
codes for proinflammatory cytokine IL-6, an important regulator
of the acute-phase response to injury and infection [39], was
downregulated in Mmp13
2/2 tissues at both 7 d and 14 d (FC,1
and FC,1.2, respectively).
Interestingly, potent and significant upregulation of the
expression of neuropeptide Y (Npy;F C ,5), a positive regulator
of angiogenesis [40–42] was observed in Mmp13
2/2 tissue as
compared to WT mice at 14 d. In addition, expression of H60a,
Cadm1 and Ifi202b genes remained elevated. In contrast, a variety
of genes associated with collagen metabolism and fibrillogenesis
(Mmp2, Mmp3, Mmp9, Tnxb/tenascin XB, Col14a1/collagen type
XIV a1) and cell adhesion and motility, and angiogenesis (e.g.
Thbs3/thrombospondin 3, Dsp/desmoplakin, Chl1/cell adhesion
molecule with homology to L1CAM, Selp/selectin P, Vtn/
vitronectin, Pdgfd/platelet-derived growth factor D, Tnxb, and
Mmp9) were down-regulated in Mmp13
2/2 granulation tissue
(Figure 4A). Interestingly, the expression of Hba-a1/hemoglobin a-
chain previously detected in granulation tissue macrophages [43]
was downregulated in Mmp13
2/2 tissue at 14 d.
At 21 d, over 10% of the differentially expressed genes were
growth factors, all downregulated in Mmp13
2/2 tissue (Figure 4B).
In addition, several genes associated with angiogenesis (e.g. Col8a1,
Col8a2/collagen VIII a1 and a2, Angpt1/angiopoietin 1 and Figf/
c-fos induced growth factor/vascular endothelial growth factor D)
were downregulated in Mmp13
2/2 granulation tissue as compared
to WT mice (Figure 4A). Moreover, genes such as Igf2/insulin-like
growth factor 2, Ptn/pleiotrophin, Pdgfd, and Figf, which function
in the positive regulation of cell division were downregulated with
FC.0.75 and P,0.05. Casp4/caspase 4, one of the ‘‘inflammatory
caspases’’ and Pdgfd, a potent inducer of cell proliferation and
Figure 2. Delayed maturation of myofibroblasts in granulation
tissue of Mmp13
2/2 mice. Sections of experimental granulation
tissue of wild type (WT) and MMP-13 knockout (Mmp13
2/2) mice were
stained with a-smooth muscle actin (a-SMA) antibody. (A) The panel
shows three representative image pairs from comparable locations of
WT and Mmp13
2/2 granulation tissue at 7 d. a-SMA-positive myofibro-
blasts were detected close to implant surface (s). The staining pattern
was denser and followed parallel orientation more strictly in WT mice
compared to Mmp13
2/2 granulation tissue. (B) (Upper panels) at 14 d,
a-SMA-staining pattern was strong and comparable in WT and
Mmp13
2/2. (Lower panels) representative image pair of WT and
Mmp13
2/2 granulation tissues at 21 d immunostained for a-SMA. The
expression of a-SMA was evident in the inner parts of implants in WT
mouse granulation tissue, whereas in the Mmp13
2/2 granulation tissue
a-SMA-positive cells were mainly abundant close to implant surface. (s,
implant surface; scale bar=100 mm).
doi:10.1371/journal.pone.0042596.g002
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P#0.001) in all time points examined in Mmp13
2/2 mice. In
contrast, Cadm1 which is shown to regulate epidermal wound
healing [46] was systematically upregulated in all time points
(Figure 4A).
Pathway analysis of differentially expressed genes in
Mmp13
2/2 and WT mouse granulation tissue
To elucidate the biological processes involved in the delayed
granulation tissue growth in Mmp13
2/2 mice, the different gene
expression profiles at specific time points were subjected to
Ingenuity Pathway Analysis (IPA). This analysis of molecular
relations was performed based on the genes that differed between
the data sets with FC.0.5 and P,0.05. Several of the
differentially expressed genes included in the gene lists in
Figure 4 were also found in the MMP-13 interaction network
including Col8A1, Col8A2 and Col14A1 and several MMPs.
Moreover, the expression of a variety of chemokines and cytokines
directly related to MMP-13, including Il6, Il1, Ccl7, Ccl4 and
Ccl13, was downregulated at 7 d and 14 d in Mmp13
2/2 tissue but
upregulated at 21 d (Figure 5).
Next, functional analysis was performed to associate biological
functions with the differentially expressed gene sets at 7 d, 14 d
and 21 d of Mmp13
2/2 granulation tissue compared to WT
(Tables 2, 3, 4). Briefly, at 7 d the differentially expressed
molecules (FC.0.5, P-value,0.05) were associated most signifi-
cantly with categories cellular growth and proliferation, cellular movement,
inflammatory response, and cell death (Table 2). However, based on
regulation z-score, significant up- or downregulation of biological
functions between genotypes at 7 d was noted only with respect to
neuronal cell death and neoplasia (Table 2). The biofunction
vasculogenesis was predicted to be upregulated in Mmp13
2/2
granulation tissue (regulation z-score 1.9). This is in accordance
with the increased density of microvessels noted in Mmp13
2/2
granulation tissue at 14 d by IHC (Figure 3).
At 14 d, the differentially expressed genes were highly
significantly associated with the biofunctions such as migration of
cells, immune response, cell death, proliferation of cells and fibrosis in
Mmp13
2/2 granulation tissue compared to WT (Table 3). Several
biofunctions associated with inflammation were significantly
down-regulated in Mmp13
2/2 granulation tissues as compared
to WT: cell movement of leukocytes, cell movement of granulocytes, cell
movement of neutrophils, inflammatory response, and adhesion of immune cells
(Table 3). The network of molecules involved in the biofunction
cell movement of leukocytes in the data set (14 d) created with IPA
included IL-6, MMP-9, and MMP-2 among other inflammation
regulatory molecules (Figure 6A). In accordance with the marked
downregulation of several MMPs in Mmp13
2/2 tissue, functional
analysis predicted the biofunctions proteolysis and metabolism of protein
to be significantly downregulated (regulation z-scores -2.13 and -
2.40, respectively) (Table 3). The network of molecules involved in
the biofunction metabolism of protein in the data set (14 d) also
included IL-6, as well as MMP-9, and MMP-2, and MMP-3
(Figure 6B). In general, the functional analysis of differentially
regulated genes at 14 d time point suggests that inflammation is
clearly downregulated in Mmp13
2/2 granulation tissue although
tissue ingrowth is not significantly delayed at this time point.
Functional analysis of the differentially expressed genes
(FC.0.5, P-value,0.05) in Mmp13
2/2 and WT granulation
tissue at 21 d, again associated most significantly with the
biological functional categories cellular movement, cell death, cellular
growth and proliferation, inflammatory response and cellular development
(Table 4). Particularly apoptosis and cell death of connective tissue cells,
were predicted to be significantly downregulated in Mmp13
2/2
tissue compared to WT (regulation z-score -3.19 and -2.14). In
accordance, functions cell survival and proliferation of different cell
types (except endothelial cells), and cellular homeostasis were
Figure 3. Altered vascular pattern in granulation tissue of Mmp13
2/2 mice. (A) Sections of experimental granulation tissue of wild-type (WT)
and MMP-13 knockout (Mmp13
2/2) mice harvested at indicated time points were immunostained for blood vessels using CD34 as a marker. The
arrowheads indicate microvessels and medium sized vessels (diameter,40 mm) and arrows indicate large vessel structures (diameter.40 mm). (s,
implant surface; scale bar=200 mm. (B) The number and the diameter of CD34-positive blood vessels were determined in defined areas of cellular
granulation tissues with digital image analysis. *Statistically significant difference in the density of microvessels (,10 mm) at 14 d and of the large
vessels (.40 mm) at 21 d (P,0.05, MannWhitney U test, n=5–6).
doi:10.1371/journal.pone.0042596.g003
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3.37). The molecular network of the genes associated with
biofunction proliferation of connective tissue cells is presented in
Figure 6C. Interestingly, at 21 d biofunctions associated with
inflammation, i.e. chemotaxis of phagocytes and chemotaxis of monocytes
were predicted to be upregulated (P,5.06E-06, regulation z-score
2.59) in Mmp13
2/2 tissue. In summary, the functional analysis of
differentially regulated genes at 21 d suggests that fibroblast
viability and proliferation, as well as inflammation are still active in
Mmp13
2/2 granulation tissue characterized by significantly
delayed tissue ingrowth at this time point, whereas in WT, cell
apoptosis involved in tissue maturation is increased.
Comparison of temporal gene expression profiles in WT
granulation tissue
To further elucidate the biological processes that are differen-
tially regulated during VCS-induced granulation tissue growth in
WT mice, IPA functional analysis was performed on genes
showing significant differential expression (FC.1, P,0.05)
between two consecutive time points. Comparison of granulation
tissue at time points 14 d and 7 d revealed altogether 3794
significantly differently expressed genes. Of these, 252 genes
displayed FC.1 (upregulated or downregulated expression at 14
vs. 7 d). Correspondingly, comparison of time point 21 d to 14 d
in WT mice revealed 2745 differently expressed genes including
252 genes with FC.1.
Functional analysis of gene expression at 14 d and 7 d identified
differentially expressed genes associated with the biofunction
categories cellular movement, cellular growth and proliferation and cell death
in highly significant manner (Table S2). Most notably, biofunc-
tions related to inflammation (inflammatory response, and migration of
phagocytes) showed significant down-regulation based on regulation
z-score. The molecular network of differentially expressed genes
with highest score (49) included genes for basement membrane
molecules Col4a1 and Col4a2, angiogenesis associated Col8a1 and
Col8a2, Mmp9, Tgfb, Pdgfrb, myofibroblast associated Actg2 (c-SMA)
and Tagln (Transgelin, Sm22), as well as less abundant fibrillar
collagen Col11a1, FACIT-collagen Col12a1 and transmembranous
collagen Col23a1, which is typically expressed in the epidermis and
binds a2b1 integrin [50] (Figure S1A). Based on microarray study,
these molecules are upregulated during granulation tissue growth
at 14 d compared to 7d. The molecular network with the second
highest score (42) included upregulated genes Mmp13, Mmp3 and
also Mmp11, Igfbp2, -3 and -4, Eln (elastin), Fbn2 (fibrillin 2), Fbln1
(fibulin 1) and Nid2 (nidogen 2). The upregulation of macrophage
MARCO receptor and hemoglobin a-chains may reflect macro-
phage influx into granulation tissue between 7 d and 14 d [43].
Comparison of the gene expression at 21 d to the gene
expression at 14 d, the functional analysis identified the biofunc-
tions involved in categories inflammatory response, cellular growth and
proliferation, cellular movement and cell death as most significantly
associated with the differentially expressed genes (Table S3). The
biofunctions inflammation, cell movement of monocytes and chemotaxis of
neutrophils appeared significantly downregulated at 21 d compared
to 14 d. Also, while contraction of muscle cells was predicted to be
upregulated at 21 d, the differentiation of muscle cells appeared
significantly downregulated. The most significant molecular
networks of the genes differentially expressed at 21 d as compared
to 14 d are presented in Figure S2.
Downregulation of Mmp2, Mmp9, and Mmp3 expression
in granulation tissue in Mmp13
2/2 mice
A specific temporal expression pattern for several MMPs was
observed in WT and Mmp13
2/2 granulation tissue (Figure 7A).
Interestingly, the expression of Mmp13 in WT mouse granulation
tissues was abundant already at 7 d and further upregulation was
noted at 14 d and 21 d (Figure 7A). The most notable differences
were observed in the expression of Mmp2, Mmp3, and Mmp9
mRNAs, which were reduced in Mmp13
2/2 granulation tissues at
14 d and 21 d time points (Figure 7A). Due to association of these
MMPs with angiogenesis, wound contraction and inflammation
[3,4,51], their expression was further analyzed with real time
qRT-PCR. In accordance with the microarray data, the expres-
sion of Mmp2, Mmp3, and Mmp9 mRNAs were significantly
increased in WT mice during the second week of granulation
tissue growth (Figure 7B). In contrast, the expression of Mmp2,
Mmp3, and Mmp9 mRNAs was not markedly altered in
Mmp13
2/2 samples at 14 d compared to 7 d and the expression
levels were significantly lower in Mmp13
2/2 than in WT mouse
tissue at 14 d. While the expression of Mmp2, Mmp3, and Mmp9
remained at the same level at 21 d time point in WT mice, the
expression of Mmp2 was significantly increased in Mmp13
2/2
tissues approaching the levels in WT (Figure 7B). The expression
of Mmp3 and Mmp9 was not significantly altered in Mmp13
2/2
mice at 21 d and remained significantly lower than in WT mice
(Figure 7B).
Reduced collagen gel contraction and MMP-2 production
by Mmp13
2/2 mouse skin fibroblasts
Contraction of mechanically unloaded 3D collagen gel by
fibroblasts reflects their motile activity related to cell adhesion
[36]. To address the motile activity of Mmp13
2/2 MSF, fibroblasts
were seeded in 3D collagenous matrix, and their morphological
appearance and collagen contraction capacity were examined.
Comparison of WT and Mmp13
2/2 MSF cultured in 3D collagen
revealed marked differences in cellular morphology. After
culturing the fibroblasts for 24 h in relatively low cell density
and in low serum, WT MSF formed numerous dendritic cell
extensions, whereas in Mmp13
2/2 MSF the cell extensions were
fewer (Figure 8A). Incubation of WT fibroblasts with TGF-b or
10% FCS resulted in stellate morphology characterized by
numerous thick cell extensions extending to surrounding ECM
and to adjacent cells. In contrast, few cell extensions were noted in
Mmp13
2/2 fibroblasts cultured in the presence of TGF-b or 10%
FCS (Figure 8A). In accordance with the altered morphology
suggesting reduced cellular contacts, the contraction of collagen
gel by Mmp13
2/2 MSF was reduced by 60% (P,0.005), as
compared to WT MSF (Figure 8B).
It has been postulated that restrained collagen gels represent a
better model for wound granulation tissue than floating gels, and
that the contraction that follows tension dissipation in collagen gel,
reflects the mechanical force generated by contraction of
fibroblasts [36]. In this respect, WT and Mmp13
2/2 MSF were
allowed to generate mechanical tension into the restrained 3D
Figure 4. Comparison of gene expression profiles in granulation tissue of Mmp13
2/2 and WT mice. (A) Microarray data of MMP-13
knockout (Mmp13
2/2) and wild type (WT) mouse granulation tissue at 7, 14 and 21 d were analyzed for differential gene expression by comparing
Mmp13
2/2 granulation tissue samples to WT. The genes, which showed significant difference (P,0.05) and FC.0.75 in the expression are illustrated
as heatmap. *Genes with FC.1 and P,0.001. (B) Differentially expressed genes at indicated time points were categorized based on molecular
function according to Ingenuity Pathway AnalysisH (IPA) software.
doi:10.1371/journal.pone.0042596.g004
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relaxation was examined. In accordance with the previous result,
WT fibroblasts contracted collagen gel about twice as efficiently as
Mmp13
2/2 MSF (Figure 8C). These results indicate reduction in
motile and contractile activity of Mmp13
2/2 MSF, which appears
to be due to altered response to serum factors and possibly to
TGF-b. When MSF were cultured in a floating 3D collagen gel
and in the presence of 10% FCS, WT MSF showed increased
MMP-2 production compared to Mmp13
2/2 MSF (Figure 8D).
Upregulation of Adamts4 and Npy expression in
granulation tissue of Mmp13
2/2 mice
Microarray analysis revealed marked upregulation of Adamts4
and Npy in Mmp13
2/2 granulation tissue at 7 d and 14 d time
points, respectively (Figure 4A). As these two genes have been
linked to angiogenesis [40–42,51], their expression in granulation
tissue was verified by qRT-PCR. The level of Adamts4 mRNA was
significantly upregulated in Mmp13
2/2 granulation tissue com-
pared to WT mice at 7 d (Figure 7C). However, at 14 d and 21 d
the expression of Adamts4 mRNA increased in WT tissue and no
marked difference between WT and Mmp13
2/2 mice was
detected (Figure 7C).
The expression level of Npy mRNA was low at 7 d in both WT
and Mmp13
2/2 tissue (Figure 7C). However, a significant
upregulation was observed at 14 d in Mmp13
2/2 tissue, as
compared to 7 d and to WT tissue (Figure 7C). At 21 d, the
expression of Npy was again downregulated in Mmp13
2/2 tissue
and was similar as in WT mice. As ADAMTS-4 and NPY are both
implicated in blood vessel formation [40–42,51], the results are
interesting with respect to the increased density of microvessels
observed by IHC at 14 d in Mmp13
2/2 granulation tissue.
Figure 5. Molecular interactions of MMP-13 with differently regulated genes in Mmp13
2/2 mouse granulation tissue compared to
WT. IPA software was employed to construct a molecular interaction network of MMP-13 with the genes that were differently expressed in MMP-13
knockout (Mmp13
2/2) granulation tissue compared to wild type (WT) in indicated time points. Interactions are based on the literature in Ingenuity
Knowledge Base. The molecules with fold change (FC) .0.3 in one of the time points were included in the figure and the molecules with FC.0.5 and
with P-value,0.05 in specific time point are highlighted with yellow color. Red color indicates upregulation and green color indicates
downregulation in Mmp13
2/2 mouse granulation tissue compared to WT. The intensity of the color implies the magnitude of FC. The arrows and
lines indicate direct (solid line) and indirect (dashed line) functional and physical interactions. The arrows show the direction of the regulation.
doi:10.1371/journal.pone.0042596.g005
Table 2. Summary of statistically significant biofunctions associated with the molecules that are differently regulated in
Mmp13
2/2 granulation tissues at day 7 compared to the corresponding WT samples (IPA Functional Analysis).
1
Category
2 Function Annotation p-value
3 Number of Molecules Regulation z-score
4
Cellular Growth and Proliferation proliferation of cells 2.19E-13 71 1.266
growth of fibroblast cell lines 8.86E-04 9 21.463
proliferation of smooth muscle cells 1.50E-03 8 1.160
Cellular Movement migration of cells 8.01E-12 51 20.369
leukocyte migration 6.48E-08 28 0.204
migration of endothelial cells 4.86E-07 13 1.226
chemotaxis 1.11E-06 19 0.929
Inflammatory Response immune response 3.55E-11 45 1.207
inflammatory response 1.55E-09 26 20.008
activation of leukocytes 1.96E-07 22 0.392
Cell Death cell death 4.78E-10 75 20.671
apoptosis 1.55E-06 54 21.579
cell death of immune cells 4.42E-06 21 1.015
cell death of connective tissue cells 3.69E-05 19 20.731
cell death of endothelial cells 5.80E-05 8 20.904
neuronal cell death 5.86E-05 19 22.707
5Others neoplasia 1.54E-11 82 2.574
rheumatic disease 1.62E-08 49 20.104
arthritis 8.00E-08 46 0.203
adhesion of connective tissue cells 6.18E-07 10 0.195
differentiation of connective tissue cells 3.83E-06 18 20.400
vasculogenesis 4.90E-06 20 1.897
1The threshold with FC.0.5 and p,0.05 was used to determine differentially expressed molecules.
2Category of related biofunctions.
3The probability that the association between a set of genes in the dataset and a related function is due to random association.
4The z-score predicts the direction of change for the function. A positive z-score indicates increased function and negative z-score indicates reduced function. An
absolute z-score of $2 is considered significant.
5Others includes categories: Cancer, Tissue Development, Cellular Development, Cardiovascular System Development and Function, Skeletal and Muscular Disorders.
doi:10.1371/journal.pone.0042596.t002
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Mmp13
2/2 granulation tissues at day 14 compared to the corresponding WT samples (IPA Functional Analysis).
1
Category
2 Function Annotation p-value
3 Number of Molecules Regulation z-score
4
Cellular Movement migration of cells 3.13E-21 86 21.761
cell movement 2.95E-19 88 21.614
cell movement of leukocytes 3.91E-10 38 22.275
cell movement of endothelial cells 7.06E-08 18 0.117
cell movement of granulocytes 7.16E-08 22 22.949
cell movement of smooth muscle
cells
6.70E-06 11 20.304
Inflammatory Response immune response 2.55E-14 66 20.960
inflammatory response 3.87E-11 36 22.078
chemotaxis of leukocytes 5.36E-07 19 21.939
cell movement of neutrophils 9.11E-06 16 22.300
quantity of phagocytes 2.20E-05 15 21.631
Cell Death cell death 3.79E-13 113 0.080
apoptosis 1.77E-11 90 20.075
cell death of blood cells 7.25E-06 28 1.102
cell death of muscle cells 5.01E-05 15 20.516
cell death of connective tissue
cells
1.72E-03 21 1.101
Cellular Growth and Proliferation proliferation of cells 1.48E-11 92 20.230
growth of cells 1.06E-10 72 20.705
proliferation of connective tissue
cells
8.19E-08 24 1.485
proliferation of epithelial cells 7.14E-07 20 0.326
proliferation of muscle cells 2.09E-05 15 20.594
Cardiovascular System Development
and Function
development of blood vessel 1.07E-09 36 20.663
angiogenesis 3.63E-09 31 20.565
endothelial cell development 2.06E-05 14 21.283
proliferation of endothelial cells 1.20E-03 10 21.827
Others
5 tumorigenesis 1.53E-18 138 20.128
tissue development 4.63E-11 89 20.785
fibrosis 2.21E-10 29 1.226
vascular disease 4.02E-10 60 21.196
differentiation of cells 3.03E-09 66 0.705
rheumatic disease 6.26E-09 68 21.800
arthritis 3.22E-08 64 21.732
differentiation of connective
tissue cells
5.00E-07 25 0.136
proteolysis 2.40E-05 14 22.125
metabolism of protein 6.75E-05 27 22.402
adhesion of immune cells 5.27E-04 15 22.557
1The threshold with FC.0.5 and p,0.05 was used to determine differentially expressed molecules.
2Category of related biofunctions.
3The probability that the association between a set of genes in the dataset and a related function is due to random association.
4The z-score predicts the direction of change for the function. A positive z-score $2 indicates increased function and negative z-score indicates reduced function. An
absolute z-score of $2 is considered significant.
5Others includes categories: Cancer, Tissue Development, Cellular Development, Connective Tissue Disorders, Cardiovascular Disease, Organismal Injury and
Abnormalities and Protein Synthesis.
doi:10.1371/journal.pone.0042596.t003
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MMPs are important players at all stages in cutaneous wound
repair [3,4]. They play a role in the clearance of ECM barriers, in
the release and activation of various bioactive proteins as well as in
the regulation of cell-ECM interactions [3,4]. In humans, MMP-
13 is not detected in normally healing adult skin wounds, although
it is expressed by fibroblasts in human fetal skin wounds
characterized by rapid healing with minimal scar [23,25]. In
mouse skin wounds, which also typically tend to heal rapidly and
do not develop scars comparable to humans, MMP-13 is suggested
to function analogously to MMP-1 in adult human skin wound
[9,12,21,22]. However, the mechanistic role of mouse MMP-13 in
the remodeling of wound ECM remains unclear.
In this study, we have examined the specific role of MMP-13 in
granulation tissue formation by utilizing a well established
experimental model of granulation tissue induction by viscose
cellulose sponge (VCS) [29,31]. This model allows precise
examination of various parameters involved specifically in
granulation tissue formation, such as tissue growth and angiogen-
esis. Using this model in MMP-13 deficient (Mmp13
2/2) mouse
strain, we noted that MMP-13 is essential for normal generation of
granulation tissue in mice. As assessed by histological parameters,
we first observed a pronounced reduction in the growth of cellular
Table 4. Summary of statistically significant biofunctions associated with the molecules that are differently regulated in
Mmp13
2/2 granulation tissues at day 21 compared to the corresponding WT samples (IPA Functional Analysis).
1
Category
2 Function Annotation p-value
3 Number of Molecules Regulation z-score
4
Cellular Movement migration of endothelial cells 1.84E-10 19 21.063
cell movement of tumor cell lines 2.90E-10 32 2.917
cell movement of muscle cells 1.63E-09 15 1.541
migration of fibroblast cell lines 4.07E-09 12 1.583
migration of vascular smooth muscle cells 3.47E-05 7 2.088
Cell Death apoptosis 1.01E-14 87 23.191
apoptosis of tumor cell lines 4.55E-10 44 22.779
cell survival 4.86E-08 42 2.21
neuronal cell death 1.37E-05 24 21.351
cell death of connective tissue cells 2.35E-05 23 22.141
apoptosis of muscle cells 6.28E-04 10 21.709
Cellular Growth and
Proliferation
proliferation of cells 6.58E-15 89 2.986
proliferation of connective tissue cells 3.06E-09 24 2.694
proliferation of tumor cell lines 3.12E-07 33 2.611
proliferation of endothelial cells 4.25E-07 14 20.488
proliferation of epithelial cells 4.41E-06 17 3.133
Inflammatory Response immune response 6.01E-12 55 0.896
inflammatory response 8.92E-09 29 1.506
cell movement of phagocytes 2.74E-08 25 0.839
chemotaxis of phagocytes 5.06E-06 14 2.594
chemotaxis of monocytes 9.84E-05 7 2.886
Cellular Development differentiation 8.72E-12 67 1.133
endothelial cell development 3.27E-10 19 20.225
differentiation of connective tissue cells 1.88E-08 25 0.905
Others
5 tumorigenesis 1.27E-24 134 20.432
angiogenesis 5.37E-11 31 20.753
development of organ 1.21E-10 60 0.929
arthritis 3.86E-09 59 20.643
vascularization 1.06E-08 15 1.323
cellular homeostasis 3.65E-07 41 3.366
lymphangiogenesis 2.54E-06 6 n.c.
1The threshold with FC.0.5 and p,0.05 was used to determine differentially expressed molecules.
2Category of related biofunctions.
3The probability that the association between a set of genes in the dataset and a related function is due to random association.
4The z-score predicts the direction of change for the function. A positive z-score indicates increased function and negative z-score indicates reduced function. An
absolute z-score of $2 is considered significant. n.c., not calculated.
5Others includes categories: Cancer, Cellular Function and Maintenance, Tissue Development, Connective Tissue Disorders, Organismal Development, Cardiovascular
System Development and Function.
doi:10.1371/journal.pone.0042596.t004
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2/2 mice during the third
postoperative week at day 21, when Mmp13
2/2 mice showed less
than 60% of the cellular tissue ingrowth, as compared to WT
mice.
A marked alteration in the orientation of myofibroblasts in the
early Mmp13
2/2 granulation tissue was also noted at day 7.
Interestingly, MMP-13 has recently been shown to play a role in
myofibroblast differentiation in vitro, suggested to be due to the
activation of TGF-b [28]. In the same study, reduction in
myofibroblast number and wound contraction was detected in
Mmp13
2/2 mice at the termination of epithelialization [28]. Our
results show that MMP-13 augments myofibroblast function as
defined by initial parallel assembly of cell masses important for the
contraction. Moreover, with respect to myofibroblast activation,
lack of MMP-13 activity appears to be compensated in vivo, since
efficient alignment of myofibroblasts comparable to WT mice was
noted in Mmp13
2/2 granulation tissue by day 14. Interestingly, at
21 d, when prominent difference in granulation tissue growth was
also noted, a-SMA positive cells were still abundant in Mmp13
2/2
tissue, while their number was already diminishing in correspond-
ing areas in WT mouse granulation tissue. This observation was
supported by gene expression profiling showing decreased
biofunctions in apoptosis, including apoptosis of connective tissue cells
and apoptosis of muscle cells,i nMmp13
2/2 mouse granulation tissue
at 21 d. However, myofibroblasts were still abundantly present in
Mmp13
2/2 tissue in the areas with strong staining of fibrous ECM
characterizing more matured ECM. Thus, the observation rather
suggests that myofibroblasts are unable to move towards inner
parts of VCS implant during delayed granulation tissue growth
Mmp13
2/2 mice.
The experiments with mouse skin fibroblasts cultured within 3D
collagen indicated that processing of TGF-b and possibly other
serum factors by MMP-13 are needed to induce morphological
changes that suggest enhanced cell adhesion and cytoskeletal
activity. This is associated with fibroblast-mediated collagen gel
contraction, which depending on the model system reflects motile
(floating gels) or contractile (restrained-relaxed gel) activity of
fibroblasts. In this study, both models showed decreased collagen
gel contraction by Mmp13
2/2 fibroblasts. Thus, MMP-13 may
augment fibroblast penetration into VCS by enhancing their
motile activity and it may also increase contractile force generated
in fibroblasts. The activity of MMP-13 may also affect cell
adhesion to matrix and to adjacent cells, which could also be
related to defective assembly of Mmp13
2/2 myofibroblasts
detected at 7 d in vivo.
Stromal expression of MMP-13 has been implicated in
angiogenesis of malignant melanoma and cutaneous SCC
[52,53] and lack of MMP-13 was reported to reduce vascular
Figure 6. Molecular interactions involved in biological functions cell movement of leukocytes and metabolism of protein at 14 d
time point, and proliferation of connective tissue cells at 21 d. The diagrams show the differentially regulated genes involved in biological
functions and the molecular interactions based on the literature in Ingenuity Knowledge Base. The expression ratios in the MMP-13 knockout
(Mmp13
2/2) granulation tissues compared to WT are visualized as heatmaps. Red color indicates upregulation and green color indicates
downregulation in Mmp13
2/2 mouse granulation tissues. The intensity of the color implies the magnitude of the FC. The arrows and lines indicate
direct (solid line) and indirect (dashed line) functional and physical interactions. The arrows show the direction of regulation. (A) Functional analysis of
differentially expressed genes (FC.0.5, P,0.05) in Mmp13
2/2 granulation tissue compared to WT (14 d) revealed enrichment in the biological
function cell movement of leukocytes (P,3.91E-10), which was predicted to be downregulated in Mmp13
2/2 mice (regulation z-score -2.28). (B)
Functional analysis was performed as in (A). Enrichment of differentially expressed genes was found in the biological function metabolism of protein
(P,6.75E-05) in Mmp13
2/2 granulation tissues, and the function was predicted to be downregulated (regulation z-score -2.40). (C) Functional analysis
was performed as in (A). Enrichment of differentially expressed genes was found in the biological function proliferation of connective tissue cells at
21 d and the function was predicted to be upregulated in Mmp13
2/2 granulation tissue compared to WT (regulation z-score 2.69).
doi:10.1371/journal.pone.0042596.g006
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has recently been implicated in corneal vascularization [54]. In the
present study, significantly higher density of small vessels in
Mmp13
2/2 granulation tissue was detected at day 14, apparently
indicating enhanced angiogenesis. Accordingly, two interesting
genes involved in angiogenesis, Adamts4 [51] and Npy [40–42],
were upregulated in Mmp13
2/2 granulation tissues at 7 and 14 d,
respectively, suggesting they could be candidate genes implicated
in increased microvessel density. Another pronounced difference
between the genotypes in terms of vascularization was the virtual
absence of large vessels at day 21 d in Mmp13
2/2 mouse tissue.
Functional analysis of the global gene expression data suggested
some increase in vasculogenesis at 7 d, which supports the
observations on the increased microvasculature at 14 d in
Mmp13
2/2 granulation tissue. Despite of upregulation of angio-
genic genes Npy, Fgf13, Met and Cyr61 [40,47,48,49] in Mmp13
2/2
Figure 7. The expression of Mmp2, Mmp3, Mmp9, Adamts4, and Npy mRNA in Mmp13
2/2 and WT mouse granulation tissue. (A)
Microarray data of MMP-13 knockout (Mmp13
2/2) and wild type (WT) mouse granulation tissue at 7, 14 and 21 d were analyzed for MMP gene
expression, and the signal intensities are illustrated as a heatmap. (B,C) Total RNA harvested from WT and Mmp13
2/2 granulation tissues at the
indicated time points was analyzed for Mmp2, Mmp3, Mmp9, Adamts4, and Npy mRNA levels by real-time qRT-PCR. A dot represents a mean of
triplicate analysis of a sample with SD#2% of the mean and the black horizontal bar represents the mean of the experimental replicates. The
amplification result of a given mRNA was normalized for b-actin mRNA level in each sample. (*P,0.05, **P,0.001, ***P,0.0001, independent
samples T-test, n=4–6).
doi:10.1371/journal.pone.0042596.g007
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expression data suggested downregulation of the process at 14 d
and at 21 d. This reflects the difference noted in the amount of
large vessels at histological level at 21 d time point. It is possible,
that the presence of large blood vessels in WT mouse granulation
tissue at 21 d was not a result of increased tissue growth, but that
the large vessels were required for proper granulation tissue
growth.
Genome wide transcriptional profiling studies of various wound
healing models in mice and humans have revealed hundreds of
differentially regulated genes in different stages of wound healing.
These include genes involved in inflammatory response, pathogen
recognition, endopeptidase activity, ECM composition and
various regulatory processes in cells [55–57]. Although laser
microdissection has enabled analysis of gene expression profiles in
specific cells [57], the majority of wound microarray studies have
not discriminated the genes expressed by epithelial cells from the
genes expressed by granulation tissue cells. Here, we performed
global gene expression profiling specifically in granulation tissue
cells excluding epidermal keratinocytes and adjacent intact tissue.
The data were analyzed with respect to the genotype and to the
temporal alterations in gene expression.
The global gene expression analysis comparing the 7 d samples
revealed several interesting genes, which were upregulated in
Mmp13
2/2 granulation tissue, such as angiogenic Adamts4 [51]
and growth inhibitory Ifi202b and Cadm1 [37,38,46]. However,
significant up- or downregulation of biological functions between
genotypes at 7 d was noted only with respect to neuronal cell death
and neoplasia. The most obvious differences between the genotypes
were observed at 14 d time point, which is in accordance with the
fact that the difference in granulation tissue growth was not
obvious until during the third week. At day 14, a significant
Figure 8. Reduced collagen gel contraction by Mmp13
2/2 mouse skin fibroblasts. (A) Skin fibroblasts (MSF) established from wild type (WT)
and MMP-13 knockout (Mmp13
2/2) mice were cultured in mechanically unloaded (floating) 3D collagen gel at density 2610
5/ml for 24 h in the
presence of 0.5% FCS, 10% FCS or 0.5% FCS+TGF-b (5 ng/ml), as indicated. The cells were fixed, stained with fluorescently labeled phalloidin and
Hoechst, and photographed with 206magnification to observe morphological appearance. In contrast to Mmp13
2/2 MSF, WT fibroblasts displayed
stellate morphology with numerous thick cell extensions in response to TGF-b or 10% FCS (Scale bar=10 mm). (B) WT and Mmp13
2/2 MSF were
cultured in mechanically unloaded 3D collagen gel at density 5610
5/ml for 24 and 48 h in the presence of 10% FCS. Contraction of collagen gels was
measured from digital images of the gels and is shown as relative to the original gel size. (*P,0.005 compared to control, Independent samples T-
test, n=4) (C) WT and Mmp13
2/2 MSF were cultured in attached 3D collagen gel at density 5610
5/ml for 72 h in the presence of 10% FCS.
Subsequently the gels were detached from the well walls and contraction was quantified after 24 h. (*P,0.005 compared to control. Independent
samples T-test, n=3). (D) MSF were cultured for 72 h in 3D collagen gel in the presence 10% FCS. Equal aliquots of conditioned media were analyzed
in gelatinase zymography.
doi:10.1371/journal.pone.0042596.g008
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observed. Il6, which was markedly downregulated in Mmp13
2/2
granulation tissue at 7 d and 14 d is one of the key molecules
regulating biofunctions, such as cell motility of leucocytes and
metabolism of protein. In fact, decreased proteolysis detected in
Mmp13
2/2 tissue may be partially due to the impaired regulation
of the composition of the inflammatory cells. Also, as inflamma-
tory cells are a major source of chemotactic molecules during
wound healing [2], deprivation of these molecules could severely
interfere with fibroblast migration in wound tissue. These results
provide evidence that in mouse wound, MMP-13 activity regulates
functions pivotal for tissue growth. Moreover, these results suggest
for the first time a role for MMP-13 in the positive regulation of
the inflammatory processes involved in wound healing. Interest-
ingly, at 21 d, the biofunctions chemotaxis of phagocytes and
proliferation of cells were markedly upregulated in Mmp13
2/2
granulation tissue, whereas apoptosis was downregulated. These
results suggest that although inflammation and growth of
granulation tissue is delayed in Mmp13
2/2 mice, it is restored at
later stage.
Comparison of the gene expression profiles of the two genotypes
at specific time points during granulation tissue development
suggested marked downregulation of several MMPs in Mmp13
2/2
tissue. Increased expression of MMP-8 (neutrophil collagenase) has
been suggested to cover the lack of the proteolytic activity of
MMP-13 in skin wound in MMP-13 deficient mice [27]. However,
in the granulation tissue model used in this study, no signs of
enzymatic redundancy were detected, as the expression of other
collagenolytic MMPs (Mmp2, Mmp8, and Mmp14) was not induced
in Mmp13
2/2 granulation tissues. Particularly, the expression of
Mmp2, Mmp3, Mmp9, and Mmp13 were upregulated during the
second week of granulation tissue growth in WT mice (Figure 7A).
Mmp13
2/2 granulation tissue did not display similar upregulation
pattern resulting in significant differences in the expression levels
of Mmp2, Mmp3, and Mmp9. Thus, MMP-13 may increase
proteolytic potential in the granulation tissue and ultimately
regulate a variety of additional biological processes via activation of
other bioactive molecules or alteration in the matrix composition.
As MMP-2 is associated with fibroblast-mediated matrix remod-
eling [58], which typically involves cellular movement, it could
promote population of VCS by fibroblasts. In addition, MMP-13
may regulate angiogenesis via stimulating Mmp2 and Mmp9
expression [59,60]. Here, the temporal induction of Mmp2 and
Mmp9 expression correlated with the appearance of large blood
vessels in WT. MMP-13 has recently been proposed to release
hepatocyte growth factor (HGF) subsequently resulting in MMP-9
induction providing a potential mechanism for MMP-13-mediated
upregulation of MMP-9 [61]. Moreover, upregulation of HGF
receptor Met expression in Mmp13
2/2 granulation tissue at all the
time points (Figure 5) may reflect disability of HGF function,
supporting this hypothesis.
Among the genes involved in cellular angiogenic, mitogenic and
locomotive activity, the expression of Pdgfd was significantly
downregulated in Mmp13
2/2 granulation tissue at all time points.
PDGF-D has been shown to stimulate proliferation of fibroblasts in
vitro, enhance activation of tissue macrophages and stabilize blood
vessels [44]. Recently, PDGF-D was reported to positively regulate
cancer related angiogenesis, cell growth and invasion, and the
expression of MMP-9 and VEGF by pancreatic cancer cells [45].
The observations that Mmp9 and VEGF-D (Figf) were both
downregulated in Mmp13
2/2 granulation tissue at 14 and 21 d,
respectively, and the receptor of PDGF-D, Pdgfrb, was upregulated
at 7 d, suggest the biological importance of the observation. Thus,
reduced expression of PDGF-D may provide a possible mecha-
nism for reduced growth and altered blood vessel pattern observed
in Mmp13
2/2 granulation tissue in later stage. Also, activation of
TGF-b by MMP-13 provides a putative explanation for our
observations, since TGF-b has been implicated in the induction of
several MMPs including MMP-9 [62] and MMP-13 [25], and in
inhibition of the expression of ADAMTS-4 in human macro-
phages [63]. However, it is of note that we could not identify
dysregulation of TGF-b signaling molecules at the examined time
points.
In conclusion, the data presented here provide evidence for the
important role of MMP-13, a multifunctional proteinase, in
regulating multiple cellular functions including myofibroblast
activity, cell motility, angiogenesis inflammation, and proteolysis
during growth and maturation of wound granulation tissue. In
addition, the results of the present study suggest possible
mechanisms of physiological function of MMP-13 in human fetal
skin wounds, and they can be employed in development of novel
therapeutic modalities for promoting impaired wound repair and
inhibiting excessive scar formation. Human MMP-13 and MMP-1
are also linked to cutaneous malignancies, such as SCC, and
melanoma [64,65], which involve inflammation, stromal cell
activation, and angiogenesis in the tumor micro-environment. It is
therefore conceivable, that the results presented in this study also
provide mechanistic insight into the role of MMP-13 and MMP-1
in the progression of these malignant tumors.
Supporting Information
Figure S1 Molecular networks of differentially ex-
pressed genes in WT granulation tissues at 14 d as
compared to 7 d. The molecular networks were created by IPA
software. (A) The molecular network with the highest significance
is composed of the molecules shown (score 49). (B) The molecular
network with the second highest significance is composed of the
molecules shown (score 42). The diagrams show the molecular
networks of differentially regulated genes and the molecular
interactions based on the literature in Ingenuity Knowledge Base.
MMPs are highlighted in yellow. The expression ratios are
visualized as heatmap. Red color indicates upregulation and green
color indicates downregulation. Only the molecules with FC.1
and P-value,0.05 are colored in red or green. Gray color
indicates FC,1. The arrows and lines indicate direct (solid line)
and indirect (dashed line) functional and physical interactions. The
arrows show the direction of regulation.
(TIF)
Figure S2 Molecular networks of differentially ex-
pressed genes in WT granulation tissues at 21 d as
compared to 14 d. The molecular networks were created by
IPA software. (A) The molecular network with the highest
significance is composed of the molecules shown (score 44). (B)
The molecular network with the second highest significance is
composed of the molecules shown (score 34). The diagrams show
the molecular networks of differentially regulated genes and the
molecular interactions based on the literature in Ingenuity
Knowledge Base. The expression ratios are visualized as heatmap.
Red color indicates upregulation and green color indicates
downregulation. Only the molecules with FC.1 and P-value
,0.05 are colored in red or green. Gray color indicates FC,1.
The arrows and lines indicate direct (solid line) and indirect
(dashed line) functional and physical interactions. The arrows
show the direction of regulation.
(TIF)
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Table S2 Summary of statistically significant biofunc-
tions associated with the molecules that are differently
regulated at day 14 compared to day 7 in WT samples
(IPA Functional Analysis).
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Table S3 Summary of statistically significant biofunc-
tions associated with the molecules that are differently
regulated at day 21 compared to day 14 in WT samples
(IPA Functional Analysis).
1
(DOC)
Acknowledgments
The expert technical assistance of Mrs. Sari Pitka ¨nen, Mrs. Johanna
Markola-Wa ¨rn, Mrs. Heidi Pakarinen, is gratefully acknowledged. The
experts at the Finnish Microarray and Sequencing Centre and Tero
Vahlberg from the Department of Biostatistics, University of Turku,
provided valuable advice for the microarray data analysis and statistical
analysis.
Author Contributions
Conceived and designed the experiments: MT ML VMK. Performed the
experiments: MT ML. Analyzed the data: MT OC VMK. Contributed
reagents/materials/analysis tools: STR ES MI SMK. Wrote the paper:
MT VMK.
References
1. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and
regeneration. Nature 453: 314–321.
2. Shaw TJ, Martin P (2009) Wound repair at a glance. J Cell Sci 122: 3209–3213.
3. Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the
regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221–233.
4. Toriseva M, Ka ¨ha ¨ri VM (2009) Proteinases in cutaneous wound healing. Cell
Mol Life Sci 66: 203–224.
5. Lee NV, Sato M, Annis DS, Loo JA, Wu L, et al. (2006) ADAMTS1 mediates
the release of antiangiogenic polypeptides from TSP1 and 2. Embo J 25: 5270–
5283.
6. Mauch C, Zamek J, Abety AN, Grimberg G, Fox JW, et al. (2010) Accelerated
wound repair in ADAM-9 knockout animals. J Invest Dermatol 130: 2120–
2130.
7. Lund LR, Rømer J, Bugge TH, Nielsen BS, Frandsen TL, et al. (1999)
Functional overlap between two classes of matrix-degrading proteases in wound
healing. Embo J 18: 4645–4656.
8. Mirastschijski U, Schnabel R, Claes J, Schneider W, A ˚gren MS, et al. (2010)
Matrix metalloproteinase inhibition delays wound healing and blocks the latent
transforming growth factor-b1-promoted myofibroblast formation and function.
Wound Repair Regen 18: 223–234.
9. Inoue M, Kratz G, Haegerstrand A, Sta ˚hle-Ba ¨ckdahl M (1995) Collagenase
expression is rapidly induced in wound-edge keratinocytes after acute injury in
human skin, persists during healing, and stops at re-epithelialization. J Invest
Dermatol 104: 479–483.
10. Nwomeh BC, Liang HX, Cohen IK, Yager DR (1999) MMP-8 is the
predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res
81: 189–195.
11. Mirastschijski U, Impola U, Jahkola T, Karlsmark T, S. A ˚gren MS, et al. (2002)
Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.
Hum Pathol 33: 355–364.
12. Vaalamo M, Weckroth M, Puolakkainen P, Kere J, Saarinen P, et al. (1996)
Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and
normally healing human cutaneous wounds. Br J Dermatol 135: 52–59.
13. Hieta N, Impola U, Lopez-Otin C, Saarialho-Kere U, Ka ¨ha ¨ri VM (2003)
Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in
culture. J Invest Dermatol 121: 997–1004.
14. Ahokas K, Skoog T, Suomela S, Jeskanen L, Impola U, et al. (2005) Matrilysin-2
(matrix metalloproteinase-26) is upregulated in keratinocytes during wound
repair and early skin carcinogenesis. J Invest Dermatol 124: 849–856.
15. Lohi J, Wilson CL, Roby JD, Parks WC (2001) Epilysin, a novel human matrix
metalloproteinase (MMP-28) expressed in testis and keratinocytes and in
response to injury. J Biol Chem 276: 10134–10144.
16. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, et al. (1997) The
activity of collagenase-1 is required for keratinocyte migration on a type I
collagen matrix. J Cell Biol 137: 1445–1457.
17. Pins GD, Collins-Pavao ME, Van De Water L, Yarmush ML, Morgan JR (2000)
Plasmin triggers rapid contraction and degradation of fibroblast-populated
collagen lattices. J Invest Dermatol 114: 647–653.
18. Freije JM, Die ´z-Itza I, Balbı ´nM ,S a ´nchez LM, Blasco R, et al. (1994) Molecular
cloning and expression of collagenase-3, a novel human matrix metalloprotei-
nase produced by breast carcinomas. J Biol Chem 269: 16766–16773.
19. Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckermann J, et al. (1995)
Expression of interstitial collagenase during skeletal development of the mouse is
restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth
Differ 6: 759–767.
20. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, et al. (1997)
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal
cells, and osteoblasts during human fetal bone development. Dev Dyn 208: 387–
395.
21. Madlener M, Parks WC, Werner S (1998) Matrix metalloproteinases (MMPs)
and their physiological inhibitors (TIMPs) are differentially expressed during
excisional skin wound repair. Exp Cell Res 242: 201–210.
22. Wu N, Jansen ED, Davidson JM (2003) Comparison of mouse matrix
metalloproteinase 13 expression in free-electron laser and scalpel incisions
during wound healing. J Invest Dermatol 121: 926–932.
23. Vaalamo M, Mattila L, Johansson N, Kariniemi A-L, Karjalainen-Lindsberg M-
L, et al. (1997) Distinct populations of stromal cells express collagenase-3 (MMP-
13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing
wounds. J Invest Dermatol 109: 96–101.
24. Ravanti L, Ha ¨kkinen L, Larjava H, Saarialho-Kere U, Foschi M, et al. (1999)
Transforming growth factor-b induces collagenase-3 expression by human
gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 274:
37292–37300.
25. Ravanti L, Toriseva M, Penttinen R, Crombleholme T, Foschi M, et al. (2001)
Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced
by transforming growth factor b via p38 mitogen-activated protein kinase.
FASEB J 15: 1098–1100.
26. Toriseva MJ, Ala-aho R, Karvinen J, Baker AH, Marjoma ¨ki VS, et al. (2007)
Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen
and promotes survival of human skin fibroblasts. J Invest Dermatol 127: 49–59.
27. Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH, et al. (2006)
Epidermal development and wound healing in matrix metalloproteinase 13-
deficient mice. J Invest Dermatol 126: 486–496.
28. Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, et al. (2009) MMP-
13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse
skin wound healing. Am J Pathol 175: 533–546.
29. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, et al. (2004) Critical
roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in
endochondral ossification. Proc Natl Acad Sci U S A 101: 17192–17197.
30. Inkinen K, Turakainen H, Wolff H, Ravanti L, Ka ¨ha ¨ri VM, et al. (2000)
Expression and activity of matrix metalloproteinase-2 and -9 in experimental
granulation tissue. Apmis 108: 318–328.
31. Laato M, Ka ¨ha ¨ri VM, Niinikoski J, Vuorio E (1987) Epidermal growth factor
increases collagen production in granulation tissue by stimulation of fibroblast
proliferation and not by activation of procollagen genes. Biochem J 247: 385–
388.
32. Farshchian M, Kivisaari A, Ala-aho R, Riihila ¨ P, Kallajoki M, et al. (2011)
Serpin peptidase inhibitor clade A member 1 (SerpinA1): a novel biomarker for
progression of cutaneous squamous cell carcinoma. Am J Pathol 179: 1110–9
33. Stokes A, Joutsa J, Ala-aho R, Pitchers M, Pennington CJ, et al. (2010)
Expression profiles and clinical correlations of degradome components in the
tumor microenvironment of head and neck squamous cell carcinoma. Clin
Cancer Res 16: 2022–2035.
34. Ala-aho R, Johansson N, Gre ´nman R, Fusenig NE, Lo ´pez-Otı ´n C, et al. (2000)
Inhibition of collagenase-3 (MMP-13) expression in transformed human
keratinocytes by interferon-c is associated with activation of extracellular
signal-regulated kinase-1,2 and STAT1. Oncogene 19: 248–257.
35. Hinz B (2010) The myofibroblast: paradigm for a mechanically active cell.
J Biomech 43: 146–155.
36. Grinnell F, Petroll WM (2010) Cell motility and mechanics in three-dimensional
collagen matrices. Annu Rev Cell Dev Biol 26: 335–361.
37. Nowacki S, Skowron M, Oberthuer A, Fagin A, Voth H, et al. (2008) Expression
of the tumour suppressor gene CADM1 is associated with favourable outcome
and inhibits cell survival in neuroblastoma. Oncogene 27: 3329–3338.
38. Xin H, Pramanik R, Choubey D (2003) Retinoblastoma (Rb) protein
upregulates expression of the Ifi202 gene encoding an interferon-inducible
negative regulator of cell growth. Oncogene 22: 4775–4785.
39. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Mu ¨ller-Newen G, et al.
(2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
Biochem J 374: 1–20.
40. Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, et al.
(2003) Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage
of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad
Sci U S A 100: 6033–6038.
MMP-13 in Wound Granulation Tissue
PLoS ONE | www.plosone.org 17 August 2012 | Volume 7 | Issue 8 | e4259641. Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, et al. (2004)
Neuropeptide Y and Y2-receptor are involved in development of diabetic
retinopathy and retinal neovascularization. Ann Med 36: 232–240.
42. Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z (2006)
Neuropeptide Y induces migration, proliferation, and tube formation of
endothelial cells bimodally via Y1, Y2, and Y5 receptors. Faseb J 20: 1924–1926.
43. Tommila M, Stark C, Jokilammi A, Peltonen V, Penttinen R, et al. (2011)
Hemoglobin expression in rat experimental granulation tissue. J Mol Cell Biol 3:
190–196.
44. Uutela M, Wirzenius M, Paavonen K, Rajantie I, He Y, et al. (2004) PDGF-D
induces macrophage recruitment, increased interstitial pressure, and blood vessel
maturation during angiogenesis. Blood 104: 3198–3204.
45. Wang Z, Kong D, Banerjee S, Li Y, Adsay NV, et al. (2007) Down-regulation of
platelet-derived growth factor-D inhibits cell growth and angiogenesis through
inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer Res 67:
11377–11385.
46. Giangreco A, Jensen KB, Takai Y, Miyoshi J, Watt FM (2009) Necl2 regulates
epidermal adhesion and wound repair. Development 136: 3505–3514.
47. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G (2003) HGF receptor up-
regulation contributes to the angiogenic phenotype of human endothelial cells
and promotes angiogenesis in vitro. Blood 101: 4816–4822.
48. Grzeszkiewicz TM, Lindner V, Chen N, Lam SC, Lau LF (2002) The
angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth
muscle cell adhesion and stimulates chemotaxis through integrin a6b1 and cell
surface heparan sulfate proteoglycans. Endocrinology 143: 1441–1450.
49. Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, et al. (2000) Curcuminoids
inhibit the angiogenic response stimulated by fibroblast growth factor-2,
including expression of matrix metalloproteinase gelatinase B. J Biol Chem
275: 10405–10412.
50. Veit G, Zwolanek D, Eckes B, Niland S, Ka ¨pyla ¨ J, et al. (2011) Collagen XXIII,
novel ligand for integrin a2b1 in the epidermis. J Biol Chem 286: 27804–27813.
51. Kahn J, Mehraban F, Ingle G, Xin X, Bryant JE, et al. (2000) Gene expression
profiling in an in vitro model of angiogenesis. Am J Pathol 156: 1887–1900.
52. Lederle W, Hartenstein B, Meides A, Kunzelmann H, Werb Z, et al. (2010)
MMP13 as a stromal mediator in controlling persistent angiogenesis in skin
carcinoma. Carcinogenesis 31: 1175–1184.
53. Zigrino P, Kuhn I, Bauerle T, Zamek J, Fox JW, et al. (2009) Stromal expression
of MMP-13 is required for melanoma invasion and metastasis. J Invest Dermatol
129: 2686–2693.
54. Lecomte J, Louis K, Detry B, Blacher S, Lambert V, et al. (2011) Bone marrow-
derived mesenchymal cells and MMP13 contribute to experimental choroidal
neovascularization. Cell Mol Life Sci 68: 677–686.
55. Chen L, Arbieva ZH, Guo S, Marucha PT, Mustoe TA, et al. (2010) Positional
differences in the wound transcriptome of skin and oral mucosa. BMC
Genomics 11: 471.
56. Cole J, Tsou R, Wallace K, Gibran N, Isik F (2001) Early gene expression profile
of human skin to injury using high-density cDNA microarrays. Wound Repair
Regen 9: 360–370.
57. Roy S, Khanna S, Rink C, Biswas S, Sen CK (2008) Characterization of the
acute temporal changes in excisional murine cutaneous wound inflammation by
screening of the wound-edge transcriptome. Physiol Genomics 34: 162–184.
58. A ˚gren MS (1994) Gelatinase activity during wound healing. Br J Dermatol 131:
634–640.
59. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, et al. (2001) Diminished
corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508: 187–190.
60. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, et al. (1998) MMP-9/
gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of
hypertrophic chondrocytes. Cell 93: 411–422.
61. Endo H, Niioka M, Sugioka Y, Itoh J, Kameyama K, et al. (2011) Matrix
metalloproteinase-13 promotes recovery from experimental liver cirrhosis in
rats. Pathobiology 78: 239–252.
62. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, et al. (2007) Mechanisms
underlying TGF-b1-induced expression of VEGF and Flk-1 in mouse
macrophages and their implications for angiogenesis. J Leukoc Biol 81: 557–566.
63. Salter RC, Arnaoutakis K, Michael DR, Singh NN, Ashlin TG, et al. (2011) The
expression of a disintegrin and metalloproteinase with thrombospondin motifs 4
in human macrophages is inhibited by the anti-atherogenic cytokine transform-
ing growth factor-b and requires Smads, p38 mitogen-activated protein kinase
and c-Jun. Int J Biochem Cell Biol 43: 805–811.
64. Johansson N, Airola K, Gre ´nman R, Kariniemi A-L, Saarialho-Kere U, et al.
(1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous
cell carcinomas of the head and neck. Am J Pathol 151: 499–508.
65. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Ka ¨ha ¨ri VM, et al.
(2002) High expression levels of collagenase-1 and stromelysin-1 correlate with
shorter disease-free survival in human metastatic melanoma. Int J Cancer 97:
432–438.
MMP-13 in Wound Granulation Tissue
PLoS ONE | www.plosone.org 18 August 2012 | Volume 7 | Issue 8 | e42596